Literature DB >> 10970400

Seroepidemiological survey of infection by feline leukemia virus and immunodeficiency virus in Madrid and correlation with some clinical aspects.

A Arjona1, E Escolar, I Soto, N Barquero, D Martin, E Gomez-Lucia.   

Abstract

A study of 180 healthy cats found that 15.6% were feline leukemia virus (FeLV) positive, 8.3% were feline immunodeficiency virus (FIV) positive, and 1.1% were FIV and FeLV positive, which corresponded to 30.4, 13.8, and 2.6, of 115 cats with FIV- and FeLV-related symptoms, respectively. Differences were seen in the sexes and ages of the populations studied. Anemia, leukopenia, and lymphopenia were the most frequent hematological abnormalities in infected cats.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10970400      PMCID： PMC87403     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom.

Authors:  M J Hosie; C Robertson; O Jarrett
Journal:  Vet Rec       Date:  1989-09-09       Impact factor: 2.695

2.  Comparative study of diagnostic testing for feline leukemia virus infection.

Authors:  R H Jacobson; N A Lopez
Journal:  J Am Vet Med Assoc       Date:  1991-11-15       Impact factor: 1.936

3.  Evaluation of feline leukemia virus diagnostic tests available for in-office use by veterinarians.

Authors:  L J Swango
Journal:  J Am Vet Med Assoc       Date:  1991-11-15       Impact factor: 1.936

Review 4.  FeLV-induced feline acquired immune deficiency syndrome. A model for human AIDS.

Authors:  W D Hardy; M Essex
Journal:  Prog Allergy       Date:  1986

5.  Comparison of four test kits for feline leukemia virus antigen.

Authors:  D M Hawks; A M Legendre; B W Rohrbach
Journal:  J Am Vet Med Assoc       Date:  1991-11-15       Impact factor: 1.936

6.  Feline immunodeficiency virus infection in cats of Japan.

Authors:  T Ishida; T Washizu; K Toriyabe; S Motoyoshi; I Tomoda; N C Pedersen
Journal:  J Am Vet Med Assoc       Date:  1989-01-15       Impact factor: 1.936

7.  [Feline immunodeficiency virus in Switzerland: clinical aspects and epidemiology in comparison with feline leukemia virus and coronaviruses].

Authors:  H Lutz; R Lehmann; G Winkler; B Kottwitz; A Dittmer; C Wolfensberger; P Arnold
Journal:  Schweiz Arch Tierheilkd       Date:  1990       Impact factor: 0.845

8.  [Epidemiology of FeLV and FIV infection in the Federal Republic of Germany].

Authors:  A Fuchs; L Binzel; M Lonsdorfer
Journal:  Tierarztl Prax       Date:  1994-06

9.  Prevalence of feline leukemia virus and antibodies to feline immunodeficiency virus in cats in Norway.

Authors:  K Ueland; H Lutz
Journal:  Zentralbl Veterinarmed B       Date:  1992-02

10.  Prevalence of feline immunodeficiency virus and other retroviral infections in sick cats in Italy.

Authors:  P Bandecchi; D Matteucci; F Baldinotti; G Guidi; F Abramo; F Tozzini; M Bendinelli
Journal:  Vet Immunol Immunopathol       Date:  1992-03       Impact factor: 2.046
View more
  18 in total

1.  Feline immunodeficiency virus subtype B in domestic cats in Minas Gerais, Brazil.

Authors:  F A Caxito; F M Coelho; M E Oliveira; M Resende
Journal:  Vet Res Commun       Date:  2006-11       Impact factor: 2.459

2.  A survey of feline leukaemia virus antigenaemia among cats in eastern Austria: a retrospective analysis of serum samples routinely tested between 1996 and 2011.

Authors:  Clair L Firth; Karin Möstl
Journal:  JFMS Open Rep       Date:  2015-07-29

3.  Prevalence of feline immunodeficiency virus and feline leukaemia virus infection in Malaysia: a retrospective study.

Authors:  Amilan Sivagurunathan; Asem M Atwa; Remo Lobetti
Journal:  JFMS Open Rep       Date:  2018-03-13

Review 4.  Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate Lentiviruses.

Authors:  Lorena de Pablo-Maiso; Ana Doménech; Irache Echeverría; Carmen Gómez-Arrebola; Damián de Andrés; Sergio Rosati; Esperanza Gómez-Lucia; Ramsés Reina
Journal:  Viruses       Date:  2018-08-17       Impact factor: 5.048

5.  Occurrence of feline immunodeficiency virus and feline leukaemia virus in Maputo city and province, Mozambique: a pilot study.

Authors:  Cesaltina Clm Tchamo; Mónica De Rugeriis; Emília V Noormahomed
Journal:  JFMS Open Rep       Date:  2019-09-10

Review 6.  Interferon-omega: Current status in clinical applications.

Authors:  Shi-Fang Li; Fu-Rong Zhao; Jun-Jun Shao; Yin-Li Xie; Hui-Yun Chang; Yong-Guang Zhang
Journal:  Int Immunopharmacol       Date:  2017-10-12       Impact factor: 4.932

7.  Survey of infectious and parasitic diseases in stray cats at the Lisbon Metropolitan Area, Portugal.

Authors:  Ana Duarte; Isabel Castro; Isabel M Pereira da Fonseca; Virgilio Almeida; Luis M Madeira de Carvalho; José Meireles; Maria I Fazendeiro; Luis Tavares; Yolanda Vaz
Journal:  J Feline Med Surg       Date:  2010-05-13       Impact factor: 2.015

8.  Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus).

Authors:  Marina L Meli; Valentino Cattori; Fernando Martínez; Guillermo López; Astrid Vargas; Miguel A Simón; Irene Zorrilla; Alvaro Muñoz; Francisco Palomares; Jose V López-Bao; Josep Pastor; Ravi Tandon; Barbara Willi; Regina Hofmann-Lehmann; Hans Lutz
Journal:  PLoS One       Date:  2009-03-09       Impact factor: 3.240

9.  Plasma electrophoretogram in feline immunodeficiency virus (FIV) and/or feline leukaemia virus (FeLV) infections.

Authors:  G Miró; A Doménech; E Escolar; V M Collado; G Tejerizo; A De Las Heras; E Gómez-Lucía
Journal:  J Vet Med A Physiol Pathol Clin Med       Date:  2007-05

Review 10.  Feline leukemia virus infection: a threat for the survival of the critically endangered Iberian lynx (Lynx pardinus).

Authors:  Marina L Meli; Valentino Cattori; Fernando Martínez; Guillermo López; Astrid Vargas; Francisco Palomares; José V López-Bao; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.